We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAOI icon
101
Applied Optoelectronics
AAOI
$7.85B
– –
-11,981
Closed -$171K
ABG icon
102
Asbury Automotive
ABG
$4.22B
– –
-1,241
Closed -$296K
ABSI icon
103
Absci
ABSI
$1.28B
– –
-265,382
Closed -$1.01M
ACAD icon
104
Acadia Pharmaceuticals
ACAD
$4.35B
– –
-35,154
Closed -$541K
ACHC icon
105
Acadia Healthcare
ACHC
$2.99B
– –
-17,673
Closed -$1.12M
ACI icon
106
Albertsons Companies
ACI
$5.57B
– –
-30,061
Closed -$556K
ACIC icon
107
American Coastal Insurance
ACIC
$505M
– –
-37,834
Closed -$426K
ACLS icon
108
Axcelis
ACLS
$3.94B
– –
-2,067
Closed -$217K
ACN icon
109
Accenture
ACN
$94.3B
– –
-1,111
Closed -$393K
ADBE icon
110
Adobe
ADBE
$94.5B
– –
-1,823
Closed -$944K
ADEA icon
111
Adeia
ADEA
$2.88B
– –
-18,254
Closed -$217K
ADMA icon
112
ADMA Biologics
ADMA
$1.97B
– –
-47,016
Closed -$940K
ADT icon
113
ADT
ADT
$5.24B
– –
-64,748
Closed -$468K
AEO icon
114
American Eagle Outfitters
AEO
$2.98B
– –
-14,470
Closed -$324K
AFCG
115
AFC Gamma
AFCG
$60.9M
– –
-191,162
Closed -$1.95M
AFL icon
116
Aflac
AFL
$64.4B
– –
-2,645
Closed -$296K
AI icon
117
C3.ai
AI
$1.37B
– –
-12,733
Closed -$309K
AIN icon
118
Albany International
AIN
$2.16B
– –
-26,848
Closed -$2.39M
ALB icon
119
Albemarle
ALB
$13.7B
– –
-5,342
Closed -$506K
ALG icon
120
Alamo Group
ALG
$2B
– –
-5,148
Closed -$927K
ALV icon
121
Autoliv
ALV
$8.76B
– –
-3,548
Closed -$331K
AMAL icon
122
Amalgamated Financial
AMAL
$1.46B
– –
-24,294
Closed -$762K
AMD icon
123
Advanced Micro Devices
AMD
$807B
– –
-1,932
Closed -$317K
AMED
124
DELISTED
Amedisys
AMED
– –
-10,072
Closed -$972K
AMN icon
125
AMN Healthcare
AMN
$1.3B
– –
-8,893
Closed -$377K
3 4
5
6 7

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.